论文部分内容阅读
本文提示用肝勃宁治疗急性黄疸型肝炎１３０例的临床疗效观察结果：临床显效９５．３５％优于对照组（齐墩果酸）８５．３８％。未见无效病例与毒性反应。ＡＬＴ平均复常时间及ＳＢ复常率均显著优于对照组，有统计学意义。现报告如下。
This article suggests that the clinical efficacy of Heibinning in treating 130 cases of acute jaundice hepatitis is as follows: clinical effective 95.35% is better than that of the control group (oleanolic acid) 85.38%. No invalid cases and toxic reactions were observed. ALT average recovery time and SB normalization rate were significantly better than the control group, with statistical significance. The report is as follows.